Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuntai capsule vs Progynova for hypoestrogenic symptoms during long-acting GnRHa therapy in endometriosis/adenomyosis
ChiCTR2400091803Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial of Kuntai in endometriosis and adenomyosis (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Change in Kupperman score. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
Kuntai
03
Conditions
endometriosisadenomyosis
Beyond the preview
Go deeper on ChiCTR2400091803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091803.